Radiolabeling, quality control and kit formulation of a new 99mTc-labeled antibiotic: 99mTc-doxycycline hyclate

[1]  M. Javed,et al.  Synthesis, characterization and biodistribution of novel amine thiophene ⁹⁹mTc labeled complex. , 2012, Pakistan journal of pharmaceutical sciences.

[2]  Ahmad Jahed Mushtaq,et al.  Direct labeling of doxorubicin with technetium-99m: its optimization, characterization and quality control , 2012, Journal of Radioanalytical and Nuclear Chemistry.

[3]  S. Sinha,et al.  (99m)Tc-labeling of ciprofloxacin and nitrofuryl thiosemicarbazone using fac-[(99m)Tc(CO)3(H2O)3] core: evaluation of their efficacy as infection imaging agents. , 2011, Metallomics : integrated biometal science.

[4]  Pat Zanzonico,et al.  Basic Sciences of Nuclear Medicine. , 2011, Medical physics.

[5]  Talebian Mohammad Hossein,et al.  FREEZE-DRIED COLD KIT FOR PREPARATION OF 99MTC-CIPROFLOXACIN AS AN INFECTION IMAGING AGENT , 2010 .

[6]  V. Tolmachev,et al.  Kit formulation for 99mTc-labeling of recombinant anti-HER2 Affibody molecules with a C-terminally engineered cysteine. , 2010, Nuclear medicine and biology.

[7]  S. Ganguly,et al.  Synthesis and evaluation of (99m)Tc-moxifloxacin, a potential infection specific imaging agent. , 2010, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[8]  M. Díez,et al.  Pharmacokinetics of doxycycline in sheep after intravenous and oral administration. , 2009, Veterinary journal.

[9]  T. Phaechamud,et al.  Antibacterial Activity and Drug Release of Chitosan Sponge Containing Doxycycline Hyclate , 2008, AAPS PharmSciTech.

[10]  M. A. Motaleb.  Preparation of 99mTc-cefoperazone complex, a novel agent for detecting sites of infection , 2007 .

[11]  M. A. Motaleb.  Preparation and biodistribution of 99mTc-lomefloxacin and 99mTc-ofloxacin complexes , 2007 .

[12]  Shuang Liu.  6‐Hydrazinonicotinamide Derivatives as Bifunctional Coupling Agents for 99mTc‐Labeling of Small Biomolecules , 2006 .

[13]  Ahmad Jahed Mushtaq,et al.  Synthesis, quality control and biodistribution of 99mTc-Kanamycin , 2006 .

[14]  A. Amine,et al.  Synthesis of 99mTc-pefloxacin: A new targeting agent for infectious foci , 2005 .

[15]  G. Slegers,et al.  Synthesis and comparison of 99mTc-enrofloxacin and 99mTc-ciprofloxacin. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  Xiaolin Tang,et al.  Design of Freeze-Drying Processes for Pharmaceuticals: Practical Advice , 2004, Pharmaceutical Research.

[17]  D. Wareham,et al.  Imaging bacterial infection with 99mTc-ciprofloxacin (Infecton) , 2002, Journal of clinical pathology.

[18]  M. Pillai,et al.  Evolution of Tc-99m in diagnostic radiopharmaceuticals. , 2001, Seminars in nuclear medicine.

[19]  W. Oyen,et al.  Radiopharmaceuticals for scintigraphic imaging of infection and inflammation , 2001, Inflammation Research.

[20]  K. Britton.  Highlights Lecture of the European Association of Nuclear Medicine and the World Federation of Nuclear Medicine and Biology Congress, Berlin 1998 , 1998, European Journal of Nuclear Medicine.

[21]  J. Bomanji,et al.  Clinical evaluation of technetium-99m infecton for the localisation of bacterial infection , 1997, European Journal of Nuclear Medicine.

[22]  F. Mettler.  1 – Radioactivity, Radionuclides, and Radiopharmaceuticals , 2012 .

[23]  Fred A. Mettler,et al.  Essentials of Nuclear Medicine Imaging , 1983 .

[24]  J. D. Gringoire.  [Practical advice]. , 1965, Clinique.